Area of research
Oncology · Biotechnology
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers, and Liver Disease Diagnosis and Treatment.
γδ T Cells Promote Steatohepatitis by Orchestrating Innate and Adaptive Immune Programming
Specialized dendritic cells induce tumor-promoting IL-10+IL-17+ FoxP3neg regulatory CD4+ T cells in pancreatic carcinoma
Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression
Macrophages in Nonalcoholic Steatohepatitis: Friend or Foe?
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice
Mincle Signaling Promotes Con A Hepatitis
Mincle suppresses Toll-like receptor 4 activation
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury
Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways
TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia